Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Allocated Share-based Compensation Expense | $ 9,952 | $ 8,958 |
| Cost of revenue [Member] | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Allocated Share-based Compensation Expense | 380 | 300 |
| Research, development and clinical trials expenses [Member] | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Allocated Share-based Compensation Expense | 1,470 | 1,316 |
| Selling, general and administrative expenses [Member] | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Allocated Share-based Compensation Expense | $ 8,102 | $ 7,342 |